🟢 Inovio Pharmaceuticals is trading 10.4% up today amid broader-market gains after cooler inflation

Inovio Pharmaceuticals is trading at $1.23, up 10.36%, with broader-market strength after cooler-than-expected inflation the most likely backdrop.

• August PCE inflation was 3.4% year over year, below the 3.7% expected.
• The Nasdaq gained more than 1% as investors reassessed near-term Fed rate-hike expectations.
• No new company-specific announcement explaining the move was identified. INO-3107 has an upcoming FDA decision targeted for October 30, 2026; available evidence does not link it directly to the move.